Bio Pharma Dive

JUNE 23, 2021

Led by CEO Samantha Singer, Abata Therapeutics has $95 million to advance its plans to engineer regulatory T cells for treating autoimmune diseases.

Engineer 336

Engineer Development 336

Pharmaceutical Technology

APRIL 6, 2023

Ginkgo Bioworks has strengthened its end-to-end R&D capabilities in gene therapy with the purchase of adeno-associated virus (AAV) capsid discovery and engineering assets from StrideBio, for an undisclosed sum. As part of the transaction, one StrideBio employee will be transferred to Ginkgo’s mammalian engineering team.

Engineer 130

Engineer Gene Therapy Gene Manufacturing 130

Medical Xpress

MAY 16, 2023

Inspired by sutures developed thousands of years ago, MIT engineers have designed "smart" sutures that can not only hold tissue in place, but also detect inflammation and release drugs.

Engineer 127

Engineer Drugs Development 127

Fierce Pharma

AUGUST 2, 2024

Adaptimmune has won accelerated FDA approval | Adaptimmune has won accelerated FDA approval for Tecelra (afami-cel), a treatment for metastatic or unresectable synovial sarcoma which becomes the first engineered cell therapy for a solid tumor and the first new treatment in the indication in more than a decade.

Engineer 133

Engineer FDA Approval 133

Pharmaceutical Technology

MARCH 22, 2024

Discover Cellectis SA's groundbreaking patent for engineered T-cells designed for immunotherapy, targeting cancer, infections, and autoimmune diseases. Learn about the innovative method and composition outlined in the patent for effective and affordable treatment.

Engineer 130

Engineer 130

Bio Pharma Dive

FEBRUARY 10, 2021

Using technology from Caribou Biosciences, AbbVie hopes to engineer "off-the-shelf" CAR-T cells that can better withstand attacks from the immune system.

Gene Editing 306

Gene Editing Gene Engineer 306

Bio Pharma Dive

SEPTEMBER 12, 2023

The two-year-old San Diego biotech is allied with The Jackson Laboratory to engineer better mouse models of the rare diseases it plans to target.

Medicine 279

Medicine Engineer 279

Bio Pharma Dive

MARCH 3, 2021

The CRISPR biotech raised $115 million in a Series C financing aimed at advancing its engineered cell therapy research.

Gene Editing 265

Gene Editing Engineer Gene Research 265

Bio Pharma Dive

APRIL 5, 2023

The deal hands Ginkgo technology for discovering and engineering capsids — the outer shell that protects the helpful genetic material in gene therapies.

Gene Therapy 262

Gene Therapy Gene Engineer Genetics 262

Pharmaceutical Technology

NOVEMBER 16, 2022

ElevateBio has entered a partnership with Affini-T Therapeutics to progress the latter’s engineered TCR-T therapies focused on Kirsten rat sarcoma viral oncogene homolog (KRAS), a dominant oncogenic driver mutation in solid tumours.

Development 246

Development Gene Therapy Engineer Gene Editing 246

Pharmaceutical Technology

SEPTEMBER 8, 2024

Interferon alfa-2b is under clinical development by Center for Genetic Engineering and Biotechnology and currently in Phase II for Genital Warts (Condylomata Acuminata).

Genetic Engineering 100

Genetic Engineering Engineer Genetics Clinical Development 100

Bio Pharma Dive

NOVEMBER 11, 2022

It’s the latest setback for Brainstorm’s NurOwn, an engineered cell therapy that has been on a winding journey since failing a key study in ALS patients two years ago.

Engineer 246

Engineer 246

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 29, 2024

(Engin Akyurt/Pixabay) If you’re in a lot of pain, being told to take deep breaths and accept the sensations in your body might not feel particularly comforting.

Engineer 244

Engineer Research Clinical Trials Clinical Trials 244

Pharma Mirror

MAY 19, 2021

Rashedi Hassan holds a Diploma in Engineering from Dhaka Polytechnic Institute. With more than 18. The post Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh appeared first on Pharma Mirror Magazine.

Sales 246

Sales Marketing Engineer Life Science 246

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 19, 2024

Engineers at the University of California San Diego (UCSD) have used cutting-edge technology to analyze the postmortem brains of 14 donors aged over 59, some of whom died with Alzheimer’s disease and some of whom […]

Engineer 246

Engineer Development Clinical Trials Clinical Trials 246

Medical Xpress

MARCH 1, 2025

Research from the University of Pittsburgh's Swanson School of Engineering aims could uncover why some people with DS develop dementia while others do not providing insight that could ultimately benefit the entire DS community.

Engineer 92

Engineer Development Research 92

Pharmaceutical Technology

MARCH 28, 2024

Discover how Synlogic Inc's patented genetically programmed microorganisms can modulate and treat diseases. Learn about the innovative method for producing pharmaceutical compositions using non-pathogenic bacteria to metabolize phenylalanine. Explore the potential applications in gut microbiome and tumor environments.

Bacteria 130

Bacteria Genetic Engineering Genetics Engineer 130

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 7, 2023

New research from ETH Zürich in Switzerland could see future wearable devices (with perhaps a few implants and a touch of genetic engineering) boost our health directly. Fitness trackers help you stay healthy by keeping count of your steps and monitoring your heart rate, driving you on to hit those cardio goals.

Genetic Engineering 246

Genetic Engineering Gene Engineer Genetics 246

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 9, 2023

Joe Dituri, a former US navy diver and expert in biomedical engineering has been living in a 55 square meter (592 square feet) space 30 feet below the […] As nightmares go, being trapped in a small box deep underwater is probably high on many people’s lists. But one US professor is doing this on purpose.

Scientist 245

Scientist Engineer Clinical Trials Clinical Trials 245

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 3, 2023

Mice engineered with genes that put them at greater risk of an Alzheimer’s-like disease had fewer amyloid plaques following the vaccine. An experimental vaccine that aims to slow down or prevent the progression of Alzheimer’s disease has been trialed in mice with promising early results.

Vaccination 246

Vaccination Vaccine Engineer Gene 246

Medical Xpress

FEBRUARY 21, 2025

The findings are published in the Journal of Neural Engineering. The technique, called "DeepFocus," uses transcranial electrical stimulation (TES) on the scalp and transnasal electrical stimulation (TnES) to achieve more accurate electrical stimulation in the brain.

Engineer 94

Engineer Development Research 94

AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 5, 2024

But type “setting a weight loss goal” into any online search engine and you’ll likely be left with more questions than answers. Sure, the many […]

Engineer 246

Engineer Clinical Trials Clinical Trials Clinical Research 246

Pharmaceutical Technology

APRIL 24, 2024

Discover how Pfizer's patented CARs targeting BCMA offer a groundbreaking method for treating cancer. Learn about the unique ligand-binding and signaling domains for effective treatment.

Engineer 130

Engineer 130

Bio Pharma Dive

NOVEMBER 15, 2023

Now independent Mural Oncology will focus on advancing a pipeline of engineered cytokines for cancer, while Alkermes has recast itself as a “pure-play” neuroscience company.

Engineer 189

Engineer Drugs 189

Bio Pharma Dive

JANUARY 2, 2024

The deal is the second startup sale engineered by University of California, Berkeley scientist Shakked Halperin, and gives Tome a way to insert or delete small DNA sequences into the genome.

Genomics 182

Genomics Genome DNA Engineer 182

BioPharma Reporter

SEPTEMBER 10, 2024

Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based medicines (OBMs), recently announced the issuance of its second US patent.

Engineer 104

Engineer Medicine 104

Pharmaceutical Technology

JULY 25, 2022

According to Tom Lenaerts, Head of Global Process Engineering at Datwyler, this transformation will reshape the entire healthcare ecosystem. Over the last year, Datwyler engineers have been working hard to connect the machinery at its Pregnana, Milanese plant in Italy.

Engineer 286

Engineer Packaging Packaging Production 286

Pharmaceutical Technology

DECEMBER 9, 2024

ZETA provides the best-in-class services and customised solutions to specific problems of its customers. Relying on efficient concepts and with…

Engineer 100

Engineer 100

pharmaphorum

NOVEMBER 26, 2024

ZENITH trial of MSD's Winrevair in PAH could add further momentum to an already impressive launch.

Engineer 97

Engineer Trials 97

BioPharma Reporter

AUGUST 21, 2024

A team of scientists from the universities of Glasgow and Tel Aviv has developed a groundbreaking method to transform the brain parasite Toxoplasma gondii into a potential vehicle for delivering therapeutic treatments directly to brain cells.

Drug Delivery Systems 97

Drug Delivery Systems Drug Delivery Scientist Engineer 97

Pharmaceutical Technology

JANUARY 5, 2023

Under the multi-year strategic partnership, Prevail will detect and advance capsids, which are clinically translatable, along with its cargo to develop the transformative genetic medicines by using Capsida’s novel adeno-associated virus (AAV) engineering platform.

Gene Therapy 237

Gene Therapy Gene Development Engineer 237

Pharma Times

FEBRUARY 10, 2025

New methodology may boost innovation in protein engineering

Engineer 133

Engineer Protein 133

Pharmaceutical Technology

APRIL 11, 2023

The finding was made as part of a study published in the journal Nature Biomedical Engineering. Kelley added: “Engineering-based tools allow you to do things that open up new areas of biology. The finding is expected to pave the way for adoptive cell therapy (ACT) to treat harder-to-reach cancer types.

Scientist 244

Scientist Engineer Clinical Trials Clinical Trials 244

Pharmaceutical Technology

JUNE 26, 2023

Lipid nanoparticles are enabling a new generation of engineered cell therapies with a push towards more complex cell engineering and gene editing for allogeneic therapies

Gene Editing 130

Gene Editing Gene Engineer 130

Pharmaceutical Technology

APRIL 15, 2024

Discover how Atrium Health's groundbreaking patent revolutionizes cancer treatment with targeted antibodies and cytotoxic cells, enhancing immune response and improving patient outcomes.

Antibody 100

Antibody Immune Response Engineer 100

Pharmaceutical Technology

APRIL 14, 2023

The company can use its mammalian cell engineering expertise and capabilities to screen CAR T-cells, to discover and optimise next-generation therapeutic candidates for its partners. All the new GD2 CAR designs developed through the partnership will be validated via in vitro screens and in vivo murine models.

In-Vivo 264

In-Vivo Gene Therapy In-Vitro Engineer 264

Pharmaceutical Technology

AUGUST 9, 2024

TCR therapies are minimally engineered and can target both cell surface antigens and intracellular antigens.

Engineer 130

Engineer 130